Vm23 and Vm24, two scorpion peptides that block human T-lymphocyte potassium channels (sub-type Kv1.3) with high selectivity and decrease the in vivo DTH-responses in rats
Details for Australian Patent Application No. 2007353147 (hide)
International Classifications
Event Publications
3 December 2009 PCT application entered the National Phase
PCT publication WO2008/139243 Priority application(s): WO2008/139243
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2007353164-Cement mortar panel with pretensed biaxial reinforcement
2007353145-Uses of north american ginseng fractions for treating leukemia
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser